It's out! Check out our pre-print below!
I am pleased to present our latest pre-print describing our identification of the long-sought triggers for target-directed microRNA degradation (TDMD) of miR-322 and miR-503, led by @ColletteLavigne and @Jaeil__Han. Read on for more info!👇 biorxiv.org/content/10.1101/…
115
Collette LaVigne retweeted
We had a really positive experience publishing this paper. Thanks to the reviewers and @GenesDev!
genesdev.cshlp.org/content/e…
Megan's (@Megan_L_Norris) pre-print on mRNA localization dictating binding partner specificity of the encoded protein now officially published in @GenesDev!
Open access paper available at this link:
genesdev.cshlp.org/cgi/conte…
It's out! Congrats to all - such a great team effort!
Excited to see our work out @CellReports! We generated multiple models of fusion-driven infantile #rhabdomyosarcoma to understand conserved disease biology and identify therapeutic opportunities. Check it out! 👇 🧫🐟🐭 @NCHforDocs @OhioStateMed
cell.com/cell-reports/fullte…
7
563
Looking for a GREAT mentor to work on pediatric sarcomas? You're in luck!
Replying to @KendallLabNCH
And we are now hiring for postdoctoral positions. If you are interested in joining our team please send me a cover letter and CV- we have a lot of exciting project opportunities!
Collette LaVigne retweeted
New work from our group! ✍️ We generated a #zebrafish her3 CRISPR/Cas9 knockout to study the role of her3/HES3 in development and provide clues for its role in tumorigenesis.
biorxiv.org/content/10.1101/…
First paper from the @KendallLabNCH and my own first first-author!
We took a rare fusion protein identifed by clinical sequencing of pediatric #rhabdomyosarcoma and developed zebrafish and mouse models to confirm the oncogenic potential and identify possible therapeutic targets
So excited our paper is up on bioRxiv focused on novel models of fusion-driven infantile #rhabdomyosarcoma.
biorxiv.org/content/10.1101/…
I got to work with Jae on this exciting project as a rotation student and joined the lab as soon as I could after! It's a beautiful story about the molecular machinery that mediates target directed microRNA decay (TDMD)
I am excited to present this work led by the very talented postdoc Jaeil Han in which we identify a ubiquitin ligase complex that promotes the degradation of microRNAs engaged with highly complementary targets. A detailed thread follows.
science.sciencemag.org/conte…
3
10
Collette LaVigne retweeted
BREAKING NEWS:
The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
Very cool new tool for lineage tracing!
Out now in @CellCellPress! Details of our new CRISPR-barcoded mouse model for inducible in vivo lineage tracing + scRNAseq, and how we used it to investigate blood stem cell behaviour in development & after myeloblation. cell.com/cell/fulltext/S0092…
4
Collette LaVigne retweeted
Pleased to present Jong-Sun Lee's work showing that antisense knockdown causes transcription termination. These reagents cannot be used in isolation to establish an RNA-mediated function for noncoding RNA loci!
cell.com/molecular-cell/full…
Collette LaVigne retweeted
Her point is true in many situations. Sometimes the fact that you even have the position is due to privileges you depended on to get there and helped you survive. Now that you're there, you can help widen the door, lower a ladder, and just in general make room for others.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Congratulations to @genkendall and best wishes in Ohio! Trainees looking for impactful projects and a fantastic mentor - check out the Kendall lab!
We’re moving! So excited to announce that I have accepted a tenure-track Assistant Professor position at @Nationwidekids 🦋 and THE @OhioState. Thanks to my mentors, friends and family for their support. Here’s to the next chapter of pediatric sarcoma research in the Kendall lab!
1
4
Collette LaVigne retweeted
A sarcoma is a rare kind of cancer. Although rare in adults, it only accounts for about 1% of all adult cancers, it represents approximately 15% of all childhood cancers. This #SarcomaAwarenessMonth, learn more from @CancerDotNet: cprit.us/2KP86eL.
Collette LaVigne retweeted
Cell line screening discovers link between gene fusions and functional fitness of tumour cells
go.nature.com/2VJ5ODS
#CancerResearch @sangerinstitute
Collette LaVigne retweeted
Nearly One-Quarter of Participants in the National Cancer Institute –Children’s Oncology Group Pediatric Molecular Analysis for Therapy Choice (MATCH) Trial Have an Actionable Molecular Alteration via @ascopost ascopost.com/News/60054?emai…
Thanks again to the @CancerDataLab and @AlexsLemonade for this practical and informative workshop!
Ever wondered what happens at a @CancerDataLab workshop? Great write-up here- ccdatalab.org/blog/2019/4/25…
3
Highly recommend the @CancerDataLab #RNAseq workshop - intense but empowering! Can't wait to get back to lab and keeping digging in our zebrafish sarcoma data myself. Thank you to @AlexsLemonade for this incredible opportunity! #zebrafish #pediatriccancer #MadeMyFirstHeatMap
mCherry is red
BFP is blue
Will these fish please get tumors?
We've got experiments to do!
#zebrafish #pediatriccancer #AcademicValentine
Spent the afternoon talking science and zebrafish with some awesome 3rd graders. They make cooler "lab solutions" than I do! #outreach #zebrafish #futurescientists
Collette LaVigne retweeted
Comment: Clinical trial regulators or anyone outside the company sponsoring the trial, generally do not see the data behind drug failure. Enrica Alteri and Lorenzo Guizzaro explain that this information is needed in order for researchers to learn from it. go.nature.com/2QMa4fh


















